A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study
一项多中心、随机、开放标签的 II 期研究,旨在探讨接受曲妥珠单抗德鲁替康治疗的晚期/复发性胃癌患者的最佳止吐治疗方案:EN-hance 研究
期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-025-02748-8
Aoyama, Toru; Ooki, Akira; Oba, Koji; Nishikawa, Kazuhiro; Kawabata, Ryohei; Honda, Michitaka; Maeda, Hiromichi; Kanda, Mitsuro; Sugiyama, Keiji; Makiyama, Akitaka; Segami, Kenki; Takahashi, Masazumi; Shindo, Yoshiaki; Namikawa, Tsutomu; Oshima, Takashi; Katayama, Aya; Shiosakai, Kazuhito; Sakamoto, Junichi